Leadgene Biomedical
Taipei, Taiwan· Est.
Leadgene Biomedical delivers premium research‑grade proteins and immunoassay kits to accelerate discovery and diagnostics worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Leadgene Biomedical delivers premium research‑grade proteins and immunoassay kits to accelerate discovery and diagnostics worldwide.
NephrologyInfectious DiseasesCell Biology
Technology Platform
Proprietary recombinant protein expression in CHO, HEK293, and E. coli coupled with custom purification and immunoassay development (ELISA, LFIA) for research‑use‑only reagents.
Opportunities
Expanding the rapid test portfolio into IVD‑cleared products and leveraging Asian market demand for locally produced high‑quality research reagents.
Risk Factors
Intense competition from global reagent suppliers and the need for regulatory approvals to transition RUO kits into clinical diagnostics.
Competitive Landscape
Competes with Thermo Fisher, Abcam, and Sino‑Biological; differentiation lies in fast custom protein production, carrier‑free formulations, and a growing focus on emerging viral diagnostics.